Identification of novel peptide biomarkers to predict safety and efficacy of cow's milk oral immunotherapy by peptide microarray
Clinical & Experimental Allergy2015Vol. 45(6), pp. 1071–1084
Citations Over TimeTop 10% of 2015 papers
Javier Martı́nez-Botas, Mónica Rodríguez‐Álvarez, Inmaculada Cerecedo, Cristina Vlaicu, M. Pastor, Diego Gómez‐Coronado, Montserrat Fernández‐Rivas, Belén de la Hoz Caballer
Abstract
We found two sets of IgE-binding peptides that can be used as novel biomarkers to predict the safety and efficacy of CM-OIT before starting treatment.
Related Papers
- → Oral Immunotherapy for Food Allergy(2017)102 cited
- → Oral Immunotherapy(2023)4 cited
- → ORAL DESENSITIZATION TO PEANUT USING AR101 PEANUT ORAL IMMUNOTHERAPY IN A ROLL-OVER SAFETY STUDY ARC002(2018)4 cited
- → O055 Immunologic effects of AR101 during characterized oral desensitization immunotherapy (CODIT) for peanut allergy(2016)
- → Oral immunotherapy for food allergy in childhood(2011)